Treatment-free remission in patients with chronic myeloid leukemia: literature review

Tyrosine kinase inhibitors have radically changed the course of chronic myeloid leukemia, significantly increasing survival and reducing the risk of disease progression. Nearly 50–70 % of patients achieve a consistently low or undetectable level of minimal residual disease – a deep molecular respons...

Full description

Saved in:
Bibliographic Details
Main Authors: A. N. Petrova, E. Yu. Chelysheva, A. G. Turkina
Format: Article
Language:Russian
Published: ABV-press 2019-10-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/367
Tags: Add Tag
No Tags, Be the first to tag this record!